Hyponatremia after pituitary surgery is presumed to be due to antidiur
esis; however, detailed prospective investigations of water balance th
at would define its pathophysiology and true incidence have not been e
stablished. In this prospective study, the authors documented water ba
lance in patients for 10 days after surgery, monitored any sodium dysr
egulation, further characterized the pathophysiology of hyponatremia,
and correlated the degree of intraoperative stalk and posterior pituit
ary damage with water balance dysfunction. Ninety-two patients who und
erwent transsphenoidal pituitary surgery were studied. To evaluate pos
terior pituitary damage, a questionnaire was completed immediately aft
er surgery in 61 patients. To examine the osmotic regulation of vasopr
essin secretion in normonatremic patients, water loads were administer
ed 7 days after surgery. Patients were categorized on the basis of pos
toperative plasma sodium patterns. After pituitary surgery, 25% of the
patients developed spontaneous isolated hyponatremia (Day 7 +/- 0.4).
Twenty percent of the patients developed diabetes insipidus and 46% r
emained normonatremic. Plasma arginine vasopressin (AVP) was not suppr
essed in hyponatremic patients during hypoosmolality or in two-thirds
of the normonatremic patients after water-load testing. Only one-third
of the normonatremic patients excreted the water load and suppressed
AVP normally. Hyponatremic patients were more natriuretic, had lower d
ietary sodium intake, and had similar fluid intake and cortisol and at
rial natriuretic peptide (ANP) levels compared with normonatremic pati
ents. Normonatremia, hyponatremia, and diabetes insipidus were associa
ted with increasing degrees of surgical manipulation of the posterior
lobe and pituitary stalk during surgery. The pathophysiology of hypona
tremia after transsphenoidal surgery is complex. It is initiated by pi
tuitary damage that produces AVP secretion and dysfunctional osmoregul
ation in most surgically treated patients. Additional events that act
together to promote the clinical expression of hyponatremia include no
natrial natriuretic peptide-related excess natriuresis, inappropriatel
y normal fluid intake and thirst, as well as low dietary sodium intake
. Patients should be monitored closely for plasma sodium, plentiful di
etary sodium replacement, mild fluid restriction, and attention to sym
ptoms of hyponatremia during the First 2 weeks after transsphenoidal s
urgery.